Cancer Drug Maker Ends Stock Drop Action, For Now
A Washington federal judge on Wednesday tossed a shareholder suit claiming a biotechnology company misled investors about the viability of its new leukemia treatment and concealed concerns the drug causes liver...To view the full article, register now.
Already a subscriber? Click here to view full article